Skip to main content
Find a Lawyer

United States Federal Circuit


GLAXO WELLCOME, INC. v. IMPAX LABS., INC., 03-1013

Because plaintiff cannot prove infringement literally or under the doctrine of equivalents, summary judgment was appropriate. There is ample evidence to find that HPC, the asserted equivalent, was a foreseeable sustained release agent for bupropion.

Appellate Information

  • Decided 01/29/2004
  • Published 01/29/2004

Judges

  • RADER, Circuit Judge., Before RADER, Circuit Judge, PLAGER, Senior Circuit Judge, and GAJARSA, Circuit Judge.

Court

  • United States Federal Circuit

Counsel

  • For Appellant:
  • Stephen B. Judlowe, Morgan Lewis & Bockius LLP, of New York, NY, argued for plaintiff-appellant.   With him on the brief were Dennis J. Mondolino, Jason A. Lief, and Timothy P. Heaton.

  • For Appellees:
  • Steven J. Lee, Kenyon & Kenyon, of New York, NY, argued for defendant-appellee.
Copied to clipboard